Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q4)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 6.24%560.08M | 6.00%2.25B | -11.84%486.32M | -14.46%484.34M | -4.49%574.81M | -11.18%2.12B | -9.38%527.2M | -15.40%551.66M | -2.14%566.23M | 4.84%601.81M |
| Cost of revenue | 2.66%516.44M | 6.18%2.16B | -10.03%463.96M | -15.31%462.67M | -6.63%557.49M | -14.88%2.04B | -10.91%503.08M | -17.25%515.67M | -8.97%546.29M | -1.18%597.08M |
| Gross profit | 80.91%43.64M | 1.64%84.78M | -37.87%22.36M | 8.66%21.67M | 266.33%17.32M | 1,540.64%83.41M | 41.51%24.12M | 24.43%35.99M | 192.52%19.94M | 115.65%4.73M |
| Operating expense | 164.34%65.39M | -24.65%103.23M | 106.35%59.15M | 61.15%27.98M | -1.47%31.99M | 29.18%137.01M | -22.28%24.74M | 66.89%28.66M | -40.88%17.36M | 17.27%32.47M |
| Selling and administrative expenses | ---- | ---- | ---- | ---- | ---- | -6.12%110.92M | ---- | ---- | ---- | ---- |
| -Selling and marketing expense | ---- | ---- | ---- | ---- | ---- | -3.28%65.2M | ---- | ---- | ---- | ---- |
| -General and administrative expense | ---- | ---- | ---- | ---- | ---- | -9.90%45.72M | ---- | ---- | ---- | ---- |
| Other operating expenses | 154.90%65.39M | -19.04%110.92M | 106.22%59.15M | 10.46%30.49M | -1.47%31.99M | 1,431.31%137.01M | 133.01%25.65M | 0.93%28.68M | -6.00%27.61M | 11.70%32.47M |
| Total other operating income | ---- | -9.77%7.68M | ---- | -75.46%2.51M | ---- | -59.53%8.51M | -89.35%916K | -99.85%17K | --10.24M | ---- |
| Operating profit | -3,431.01%-21.75M | 65.57%-18.45M | -602.31%-36.79M | -344.13%-6.31M | 47.11%-14.67M | 52.09%-53.59M | 95.83%-616K | -37.66%7.32M | 105.07%2.58M | 52.08%-27.74M |
| Net non-operating interest income (expenses) | 74.93%-2.54M | -55.64%-40.44M | 53.92%-4.58M | 22.70%-8.07M | 1.01%-9.81M | 12.70%-25.99M | -20.57%-10.15M | -25.24%-9.94M | -45.45%-10.44M | -59.03%-9.91M |
| Non-operating interest income | -10.91%580K | -44.58%3.06M | 222.04%2.72M | 26.20%1.03M | -5.33%710K | 92.73%5.52M | -25.09%651K | 62.62%844K | 106.35%813K | -30.62%750K |
| Non-operating interest expense | -71.07%3.12M | 38.08%43.5M | -32.33%7.3M | -19.16%9.1M | -1.31%10.52M | -3.45%31.5M | 16.30%10.8M | 27.54%10.79M | 48.62%11.26M | 45.78%10.66M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -631.11%-717K | 72.03%-351K | -335.59%-556K | 79.83%-144K | -500.00%-48K | 35.51%-1.26M | 231.07%135K | 310.71%236K | 2.46%-714K | 99.20%-8K |
| Special income (charges) | 288.79%404K | |||||||||
| Less:Write off | ---- | ---- | ---- | ---- | ---- | -288.79%-404K | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -135.36%-25.01M | 26.71%-59.25M | -1,659.42%-41.93M | -69.39%-14.52M | 34.86%-24.53M | 43.78%-80.83M | 54.80%-10.63M | -164.46%-2.38M | 85.43%-8.57M | 42.17%-37.66M |
| Income tax | 323.31%5.39M | 15.07%-2.66M | -1,792.06%-1.19M | -1,238.57%-937K | -468.14%-642K | 59.42%-3.13M | 27.22%-2.42M | 91.47%-63K | 82.93%-70K | 96.53%-113K |
| Net income | -2,957.61%-30.41M | -86.11%-55.62M | 144.64%2.82M | 30.99%-7.47M | 34.86%-25.75M | 78.91%-29.89M | 106.03%1.06M | -471.68%-6.33M | 82.27%-10.82M | 38.92%-39.54M |
| Net income continuous operations | -270.25%-30.41M | 27.18%-56.59M | -1,655.82%-40.74M | -59.77%-13.59M | 36.38%-23.89M | 42.89%-77.7M | 59.34%-8.21M | -152.30%-2.32M | 85.45%-8.5M | 39.31%-37.55M |
| Net income discontinuous operations | --0 | -97.99%963K | 1,187.34%43.56M | 363.89%6.12M | 6.33%-1.86M | 943.26%47.81M | 264.34%9.28M | -46.53%-4.01M | 11.43%-2.32M | 30.58%-1.99M |
| Noncontrolling interests | 2,520.00%131K | 2,662.50%221K | -49.02%52K | -219.67%-73K | -213.21%-60K | 102.78%8K | -98.23%5K | 148.78%102K | 119.30%61K | 117.91%53K |
| Net income attributable to the company | -2,983.47%-30.54M | -86.80%-55.84M | 143.12%2.77M | 32.04%-7.4M | 35.10%-25.69M | 78.86%-29.9M | 105.91%1.06M | -487.00%-6.43M | 82.08%-10.88M | 38.56%-39.59M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -2,983.47%-30.54M | -86.80%-55.84M | 143.12%2.77M | 32.04%-7.4M | 35.10%-25.69M | 78.86%-29.9M | 105.91%1.06M | -487.00%-6.43M | 82.08%-10.88M | 38.56%-39.59M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -1,227.78%-0.0203 | -217.63%-0.0937 | 118.52%0.002 | 32.24%-0.0124 | 35.09%-0.0431 | 87.56%-0.0295 | 105.98%0.0018 | -485.71%-0.0108 | 82.02%-0.0183 | 38.58%-0.0664 |
| Diluted earnings per share | -1,227.78%-0.0203 | -217.63%-0.0937 | 118.52%0.002 | 32.24%-0.0124 | 35.09%-0.0431 | 87.56%-0.0295 | 105.98%0.0018 | -485.71%-0.0108 | 82.02%-0.0183 | 38.58%-0.0664 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.